Article
Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Apr 2012
Himoudi N, Wallace R, Parsley K L, Gilmour K, Barrie A-U, Howe K, Dong R, Sebire N J, Michalski A, Thrasher A J, Anderson J
Abstract excerpt
BACKGROUND: Immunotherapy using autologous dendritic cell (DC) vaccination has not been systematically evaluated in osteosarcoma. We therefore conducted a phase I trial to assess feasibility, safety and tumour-specific immune responses in patients with relapsed disease. PATIENTS AND METHODS: Of 1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.